Navigation Links
Covance to Present at the Drug Information Association's 45th Annual Meeting
Date:6/16/2009

sion Chair: Ann Flandermeyer, BSN, PhD, MSN, RN, senior director, project management and clinical operations, clinical development services

  • "Preserving Relationships in the Face of Divergent Project Expansions"

8:30 a.m. | Speaker: Mike Hill, project manager, periapproval services

  • "Preclinical Safety Evaluation of Novel Adjuvants and Vaccines"

10:30 a.m. | Session Chair: Peter Thomas, PhD, senior program manager, strategic partnering & integrated drug development

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 25 countries, and more than 9,600 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

About the Drug Information Association (DIA)

DIA serves more than 30,000 biopharmaceutical professionals from industry, academia, and regulatory agencies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215.442.6100.

St
'/>"/>

SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Covance Elects John McCartney to Companys Board of Directors
2. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
3. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
4. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
5. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
6. Covance Purchases Equity Stake in Caprion Proteomics
7. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
8. Covance Decides to Pursue Its Original Preclinical Strategy in China
9. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
10. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
11. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Reston, VA (PRWEB) January 15, 2014 ... education have continued their sponsorship of an annual competition ... interest in, and access to, innovative STEM study. The ... , TEAMS: Tests of Engineering Aptitude, Mathematics, and ...
(Date:1/15/2014)... 2013 was a banner year of continued innovation ... continued independent research led by the team at Wake ... million grant from the Susanne Marcus Collins Foundation, had ... reviewed journal, Amy Grant highlighted Brainwave Optimization® in First ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... January 14, 2014 Histogen, Inc., a ... of cells grown under simulated embryonic conditions, today announced ... with Suneva Medical, Inc. for physician-dispensed aesthetic products containing ... , This agreement is an amendment to the existing ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... CALGARY , June 1 /PRNewswire-FirstCall/ - Oncolytics ... that it has received approval from the Belgian Federal ... its Phase 3 trial examining REOLYSIN in combination with ... neck cancers. This is the same trial that was ...
... development that could lead to novel carbon composites and ... Institute of Technology today unveiled a new method for ... graphene. The research is available online in the ... graphene sheets make graphite, which has been commonly used ...
... SHENZHEN, China , May 28 /PRNewswire-Asia-FirstCall/ -- Huiheng Medical,Inc. (OTC ... China , will host a conference call,discussing its financial results for the period ended ... , , , ... , , ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 2Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 3Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 4Liquid method: pure graphene production 2Huiheng Medical, Inc. Announces Conference Call to Discuss First Quarter 2010 Results 2
(Date:4/17/2014)... Professor Luca Razzari of the nergie Matriaux Tlcommunications ... from the John R. Evans Leaders Fund of ... acquisition of state-of-the-art biotech and nanophotonics equipment. To ... the Ministre de l,Enseignement suprieur, de la Recherche, ... These new laboratories will help us develop new ...
(Date:4/17/2014)... University engineer has developed a patented technique that ... devices. The same technique could help police during ... and Kay L. Theede chair in engineering and ... his research team have created a template-based system ... trunks. The distance detection method called stand-off ...
(Date:4/17/2014)... If a restaurant ... he can expect his premises to be trashed. Warnings like ... is enough to make restaurant owners pay up. Similarly, mafia-like ... in other birds, nests. If the host birds throw the ... destroying the entire nest. Consequently, it is beneficial for hosts ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3
... Ebola virus, an emerging public health concern in Africa ... feared of exotic pathogens. Due to its virulent ... scientists studying the agent have had to work under ... few highly specialized labs and hampering the ability of ...
... FOR IMMEDIATE RELEASE From and for ... and Food Chemistry Wishing your Valentine good heart ... consider the food some people love to hate, and hand ... box of chocolates. Researchers in Connecticut are reporting impressive new ...
... A study by the University of Exeter has ... wild for conservation projects. Published online in the ... survival rates of captive carnivores that are released ... in three captive-born carnivores survives in the wild, ...
Cached Biology News:Ebola virus disarmed by excising a single gene 2Ebola virus disarmed by excising a single gene 3American Chemical Society's Weekly PressPac -- Jan. 16, 2008 2American Chemical Society's Weekly PressPac -- Jan. 16, 2008 3American Chemical Society's Weekly PressPac -- Jan. 16, 2008 4American Chemical Society's Weekly PressPac -- Jan. 16, 2008 5American Chemical Society's Weekly PressPac -- Jan. 16, 2008 6American Chemical Society's Weekly PressPac -- Jan. 16, 2008 7American Chemical Society's Weekly PressPac -- Jan. 16, 2008 8American Chemical Society's Weekly PressPac -- Jan. 16, 2008 9Captive carnivores not up to wild living 2
... trinor Prostaglandin F2α isopropyl ester (15(R)-17-phenyl ... latanoprost-related isomer containing both a double ... (β) hydroxyl group at C-15. Similar ... ester is a potential impurity in ...
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. Feature: tissue-culture treated yes ... cm 2 D H 60 ...
... bind specifically to Fc regions of many ... conjugates are commonly used as affinity adsorbents ... from serum, hybridoma ascites fluids, tissue culture ... are also commonly used to capture immune ...
... min) assay can detect H2O2 or peroxidase ... H2O2 oxidizes ADHP in a 1:1 stoichiometry ... at 530-571 nm, emission at 590-600 nm). ... a one-step, homogeneous, no wash assay system. ...
Biology Products: